Currently, the only diagnostic system is the colonoscopy, that has to be performed by an specialized doctor and requires to anaesthetize the patient. The main disadvantages associated with colonoscopy are the risk of death related to anesthesia, the possibility of intestinal perforation and the high cost. Colonoscopy is applied to patients with suspected CCR, patients with CCR as monitoring, and patients with CCR with genetic factor.
The use of new RAID-CRC of GoodGut will allow to accurately discern between those with high indicators of CCR from the ones with low indicators. Also, cancer will be detected in early stages which will allow to prevent the disease; it will be optimized the number of colonoscopies performed (only a third of the current) and there will be a desaturation of waiting lists; and the costs will be reduced (the implementation of RAID-CRC in the health system will represent a saving of 30 million euros in colonoscopies).
At what stage is now RAID-CRC?
Wee are working on clinical validation (Phase I) ending in early 2017 and which involves the University Hospital Dr. Josep Trueta, the Bellvitge University Hospital and the Catalan Institute of Oncology. To finance this stage, we have received a grant of 1.1 million euros from Retos program of the Spanish Ministry of Economy. RAID-CRC has the European patent.
What currently exists?
- 6 weeks of waiting
- Approximately 600 €
What RAID-CRC will allow?
- 1 hour of waiting approximately
- Approximately 40 €
- Biomarkers in stool samples
With the theme Advancing Knowledge, Improving Care, Barcelona played host to the 12th ...
GoodGut was the only Catalan company selected by the European Commission Executive Agency ...
Michael Lawson, MD explains the mechanisms behind the symptoms of IBS and chronic ...